These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 7083175)
1. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity. Abe I; Saito S; Hori K; Suzuki M; Sato H Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175 [TBL] [Abstract][Full Text] [Related]
2. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy. Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322 [TBL] [Abstract][Full Text] [Related]
3. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response. Riva CM; Rustum YM Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596 [TBL] [Abstract][Full Text] [Related]
4. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells. Gandhi V; Plunkett W Cancer Res; 1988 Jan; 48(2):329-34. PubMed ID: 3335008 [TBL] [Abstract][Full Text] [Related]
5. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy. Gandhi V; Estey E; Du M; Keating MJ; Plunkett W Clin Cancer Res; 1997 Sep; 3(9):1539-45. PubMed ID: 9815841 [TBL] [Abstract][Full Text] [Related]
6. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity. Tanaka M; Yoshida S Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933 [TBL] [Abstract][Full Text] [Related]
7. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine. Liliemark JO; Plunkett W; Dixon DO Cancer Res; 1985 Nov; 45(11 Pt 2):5952-7. PubMed ID: 4053067 [TBL] [Abstract][Full Text] [Related]
8. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate. Liliemark JO; Plunkett W Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676 [TBL] [Abstract][Full Text] [Related]
9. Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines. Kees UR; Ford J; Dawson VM; Piall E; Aherne GW Cancer Res; 1989 Jun; 49(11):3015-9. PubMed ID: 2720661 [TBL] [Abstract][Full Text] [Related]
10. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy. Plunkett W; Hug V; Keating MJ; Chubb S Cancer Res; 1980 Mar; 40(3):588-91. PubMed ID: 6937239 [TBL] [Abstract][Full Text] [Related]
11. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells. Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR Cancer Treat Rep; 1985; 69(7-8):851-7. PubMed ID: 4016794 [TBL] [Abstract][Full Text] [Related]
12. Effect of amsacrine on ara-CTP cellular pharmacology in human leukemia cells during high-dose cytarabine therapy. Plunkett W; Nowak B; Keating MJ Cancer Treat Rep; 1987 May; 71(5):479-83. PubMed ID: 3567973 [TBL] [Abstract][Full Text] [Related]
13. Prediction of sensitivity to 1-beta-D-arabinofuranosylcytosine by the plateau level of its 5'-triphosphate in human lymphoblastic cell lines in vitro. Abe I; Saito S; Hori K; Suzuki M; Sato H Eur J Cancer Clin Oncol; 1983 Jul; 19(7):941-4. PubMed ID: 6576907 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells. Roberts D; Peck C; Hilliard S; Wingo W Cancer Res; 1979 Oct; 39(10):4048-54. PubMed ID: 476642 [TBL] [Abstract][Full Text] [Related]
15. 1-beta-D-arabinofuranosylcytosine nucleotide inhibition of sialic acid metabolism in WI-38 cells. Myers-Robfogel MW; Spataro AC Cancer Res; 1980 Jun; 40(6):1940-3. PubMed ID: 7371029 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine. Bhalla K; Nayak R; Grant S Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology of intracellular cytosine-arabinoside-5'-triphosphate in malignant cells of pediatric patients with initial or relapsed leukemia and in normal lymphocytes. Koehl U; Hollatz G; Rohrbach E; Visschedyk K; Cinatl J; Kornhuber B; Kreuter J; Mutschler E; Schwabe D Cancer Chemother Pharmacol; 2007 Sep; 60(4):467-77. PubMed ID: 17171362 [TBL] [Abstract][Full Text] [Related]
18. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells. Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333 [TBL] [Abstract][Full Text] [Related]
19. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells. Walsh CT; Craig RW; Agarwal RP Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943 [TBL] [Abstract][Full Text] [Related]
20. Effects of hydroxyurea and thymidine derivatives on the uptake and metabolism of deoxycytidine and arabinofuranosylcytosine in log phase and contact-inhibited human diploid fibroblasts. Snyder RD; Malick NC Mol Pharmacol; 1985 Dec; 28(6):574-80. PubMed ID: 4079913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]